{"gene":"MUL1","run_date":"2026-04-29T11:37:56","timeline":{"discoveries":[{"year":2008,"finding":"MULAN/MUL1 is a mitochondrial outer membrane protein with two transmembrane domains mediating localization and a C-terminal RING finger domain exposed to the cytosol that confers E3 ubiquitin ligase activity; both intact RING finger and correct subcellular localization are required for regulation of mitochondrial dynamics and NF-κB activation.","method":"Ectopic expression and RNAi knockdown with imaging, domain mutagenesis, subcellular fractionation","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (imaging, RNAi, mutagenesis) in foundational discovery paper with >600 citations","pmids":["18213395"],"is_preprint":false},{"year":2009,"finding":"MAPL/MUL1 functions as the first mitochondria-anchored SUMO E3 ligase; it SUMOylates DRP1 to stimulate mitochondrial fission.","method":"Biochemical SUMOylation assays, overexpression and RNAi knockdown, co-immunoprecipitation","journal":"EMBO reports","confidence":"High","confidence_rationale":"Tier 1-2 — in vitro biochemical assay combined with RNAi and overexpression, >280 citations","pmids":["19407830"],"is_preprint":false},{"year":2008,"finding":"GIDE/MUL1 induces apoptosis via caspase activation and JNK-dependent cytochrome c and Smac release; the pro-apoptotic activity requires its E3 ubiquitin ligase (RING finger) activity.","method":"Overexpression, caspase inhibitor treatment, dominant-negative caspase-9, JNK inhibition, RING finger mutagenesis","journal":"Cell research","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal functional assays with mutagenesis confirming enzymatic requirement","pmids":["18591963"],"is_preprint":false},{"year":2014,"finding":"MUL1 acts in parallel to the PINK1/parkin pathway by ubiquitinating Mitofusin (Mfn) to target it for proteasomal degradation, thereby maintaining mitochondrial integrity; MUL1 suppresses PINK1 or parkin mutant phenotypes in Drosophila and compensates for their loss in mammals.","method":"Drosophila genetic epistasis, loss-of-function double mutants, mouse cortical neuron degeneration assay, ubiquitination assay","journal":"eLife","confidence":"High","confidence_rationale":"Tier 1-2 — genetic epistasis across two species plus biochemical ubiquitination assay, >260 citations","pmids":["24898855"],"is_preprint":false},{"year":2015,"finding":"During apoptosis, MAPL/MUL1-dependent SUMOylation of Drp1 stabilizes ER/mitochondrial contact sites required for mitochondrial constriction, calcium flux, cristae remodeling, and cytochrome c release; MAPL acts downstream of BAX/BAK activation.","method":"MAPL knockout/knockdown, SUMOylation assay, live imaging of ER-mitochondria contacts, cytochrome c release assay, BAX/BAK oligomer analysis","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods including KO, biochemical assays, and live imaging; >270 citations","pmids":["26384664"],"is_preprint":false},{"year":2012,"finding":"MULAN/MUL1 negatively regulates Akt by directly interacting with and ubiquitinating phosphorylated Akt, leading to its proteasomal degradation and suppression of cell proliferation and viability.","method":"Co-immunoprecipitation, in vitro ubiquitination assay, in vivo ubiquitination assay, cell proliferation/viability assays","journal":"Cell research","confidence":"High","confidence_rationale":"Tier 1-2 — in vitro and in vivo ubiquitination with reciprocal Co-IP and functional readout","pmids":["22410793"],"is_preprint":false},{"year":2016,"finding":"MUL1 and PARKIN play redundant roles in elimination of paternal mitochondria via mitophagy in mouse embryos; the process requires mitochondrial depolarization, FIS1, P62, and PINK1 kinase.","method":"Mouse embryo mitophagy assay, autophagosome/lysosome tracking, genetic knockouts of PARKIN and MUL1, pre-implantation embryo culture","journal":"eLife","confidence":"High","confidence_rationale":"Tier 2 — genetic KO combined with live imaging and functional mitophagy readout in physiologically relevant embryo model; >275 citations","pmids":["27852436"],"is_preprint":false},{"year":2015,"finding":"MUL1 ubiquitinates ULK1 (a key autophagy kinase) which partially translocates to mitochondria after selenite treatment, providing a mechanism for MUL1-regulated mitophagy.","method":"Co-immunoprecipitation, ubiquitination assay, subcellular fractionation, ULK1/ATG5 knockdown","journal":"Autophagy","confidence":"Medium","confidence_rationale":"Tier 2 — Co-IP and ubiquitination assay in single study","pmids":["26018823"],"is_preprint":false},{"year":2014,"finding":"MUL1 E3 ligase interacts with four E2 ubiquitin-conjugating enzymes (Ube2E2, Ube2E3, Ube2G2, Ube2L3); the MUL1-Ube2E3 complex recruits GABARAP via an LC3-interacting region (LIR) in the MUL1 RING domain, linking MUL1 to mitophagy.","method":"Modified yeast two-hybrid screen with MUL1-E2 fusion proteins, Co-IP, LIR mutagenesis","journal":"Cellular signalling","confidence":"Medium","confidence_rationale":"Tier 2-3 — yeast two-hybrid plus Co-IP, single lab study","pmids":["25224329"],"is_preprint":false},{"year":2014,"finding":"Omi/HtrA2 mitochondrial serine protease degrades Mulan/MUL1 as a specific substrate during oxidative stress; loss of Omi/HtrA2 protease activity causes MUL1 accumulation, decreased Mfn2 levels, and increased mitophagy.","method":"Substrate identification by protease assay, Omi/HtrA2 knockout MEFs and mnd2 mouse tissues, immunoblotting for Mfn2 and mitophagy markers","journal":"Biochimica et biophysica acta","confidence":"Medium","confidence_rationale":"Tier 2 — genetic KO model plus biochemical protease-substrate relationship, single lab","pmids":["24709290"],"is_preprint":false},{"year":2013,"finding":"MUL1 localizes to mitochondria where it interacts with MAVS and catalyzes post-translational modifications of RIG-I that inhibit RIG-I-dependent NF-κB and IFN-β signaling; MUL1 depletion potentiates antiviral responses.","method":"Co-immunoprecipitation (MUL1-MAVS, MUL1-RIG-I), RNAi knockdown, NF-κB and IFN-β reporter assays, Sendai virus/poly I:C challenge","journal":"Immunology and cell biology","confidence":"Medium","confidence_rationale":"Tier 2-3 — Co-IP with functional reporter assays in single study","pmids":["23399697"],"is_preprint":false},{"year":2017,"finding":"MAPL/MUL1 is required for SUMOylation of RIG-I upon Sendai virus infection; RIG-I SUMOylation is a prerequisite for RIG-I activation and antiviral gene transcription. A constitutively active RIG-I bypasses the MAPL requirement.","method":"MAPL knockout (in vivo and in vitro), BioID proximity labeling, SUMOylation assay, constitutively active RIG-I epistasis","journal":"Scientific reports","confidence":"High","confidence_rationale":"Tier 2 — KO genetics with BioID interactome and epistasis showing MAPL acts upstream of RIG-I activation","pmids":["28273895"],"is_preprint":false},{"year":2014,"finding":"Mitochondrial hyperfusion promotes NF-κB activation through MULAN/MUL1 in a RING domain-dependent manner; MULAN forms a complex with TRAF2 and modulates its ubiquitylation as a transmitter of NF-κB signaling.","method":"Dominant-negative Drp1 overexpression, MARCH5 overexpression, MULAN knockdown, Co-IP of MULAN-TRAF2, NF-κB reporter assay","journal":"The FEBS journal","confidence":"Medium","confidence_rationale":"Tier 2-3 — Co-IP and functional reporter with RNAi, single lab study","pmids":["24841215"],"is_preprint":false},{"year":2018,"finding":"MUL1 ubiquitinates HSPA5/GRP78 via K48-linked ubiquitination at lysine 446, leading to HSPA5 degradation and consequent lysosomal inhibition in head and neck cancer cells.","method":"Co-immunoprecipitation, K48-linked ubiquitination assay with K446 site mutation, MUL1 CRISPR knockout, Western blot","journal":"Autophagy","confidence":"Medium","confidence_rationale":"Tier 2 — site-specific mutagenesis of ubiquitination site plus KO validation, single lab","pmids":["29260979"],"is_preprint":false},{"year":2019,"finding":"MUL1 deficiency increases Mfn2 activity, triggering mitochondrial hyperfusion and acting as an ER-mitochondria tethering antagonist; reduced ER-Mito coupling elevates cytoplasmic Ca2+ which activates calcineurin and induces Drp1-dependent mitochondrial fragmentation and Parkin-mediated mitophagy. Overexpressing Mfn2 (not Mfn1) phenocopies MUL1 deficiency.","method":"MUL1 knockout neurons, live imaging of ER-Mito contacts, Ca2+ measurements, Mfn2 overexpression, PTPIP51 rescue, calcineurin inhibition","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (KO, live imaging, Ca2+ measurements, rescue experiments) in single rigorous study","pmids":["31409786"],"is_preprint":false},{"year":2019,"finding":"The MUL1 RING domain adopts a ββαβ fold with a canonical cross-brace zinc-coordination motif; it interacts directly with the p53 transactivation domain 2 subdomain (residues 39-57) as determined by NMR chemical shift perturbation.","method":"NMR solution structure determination, NMR chemical shift perturbation experiments","journal":"Biochemical and biophysical research communications","confidence":"High","confidence_rationale":"Tier 1 — NMR structure with binding site mapping","pmids":["31235254"],"is_preprint":false},{"year":2022,"finding":"The MUL1 RING domain recruits both UBE2D2 and its substrate p53-TAD simultaneously; RING binding induces closed conformation of UBE2D2~Ub, and substrate binding affinity to the RING:UBE2D2~Ub complex is enhanced compared to either alone, explaining ubiquitylation of intrinsically disordered p53-TAD.","method":"Complex structure determination, oxyester mimetic UBE2D2~Ub assays, mutagenesis (N77A, S22R/C85S), binding affinity measurements","journal":"The FEBS journal","confidence":"High","confidence_rationale":"Tier 1 — structural and biochemical reconstitution with mutagenesis","pmids":["35048531"],"is_preprint":false},{"year":2020,"finding":"MUL1 ubiquitinates UBXN7 (cofactor of the CRL2VHL ligase complex) via K48-linked ubiquitination; MUL1 inactivation leads to UBXN7 accumulation, increased HIF-1α levels, reduced oxidative phosphorylation, and increased glycolysis.","method":"Co-immunoprecipitation, ubiquitination assay, MUL1 knockout cells, metabolic flux analysis, mitochondrial respiration assay","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 — Co-IP and ubiquitination with KO metabolic phenotype, single lab","pmids":["32005965"],"is_preprint":false},{"year":2020,"finding":"MUL1 stabilizes PINK1 on the outer mitochondrial membrane in a gemcitabine-dependent manner, independently of mitochondrial depolarization, leading to Parkin-independent mitophagy.","method":"Gemcitabine treatment, PINK1 stabilization assay, MUL1 knockdown, mitophagy flux assay","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2-3 — knockdown with functional mitophagy readout, single lab","pmids":["32001742"],"is_preprint":false},{"year":2022,"finding":"MUL1 regulates Akt2 and HIF-1α protein levels through K48-specific polyubiquitination; absence of MUL1 leads to accumulation of both substrates and a metabolic shift from oxidative phosphorylation to glycolysis.","method":"MUL1 knockout cells, metabolomics, lipidomics, gene expression profiling, metabolic flux analysis, Akt2 KO cells, chemical inhibitors/activators","journal":"Frontiers in cell and developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 — KO with multiple orthogonal metabolic analyses, single lab","pmids":["35846359"],"is_preprint":false},{"year":2023,"finding":"MAPL/MUL1 promotes Drp1 SUMOylation (SUMO1 modification) in the mitochondria, facilitating Drp1 mitochondrial translocation and mitochondrial fission; SENP5 negatively regulates Drp1 SUMOylation.","method":"MAPL overexpression/silencing, Drp1 SUMO-acceptor lysine mutation, AAV in vivo overexpression, SENP5 overexpression, mitochondrial fractionation","journal":"Bone research","confidence":"Medium","confidence_rationale":"Tier 2 — mutagenesis and in vivo rescue, single lab","pmids":["40796734"],"is_preprint":false},{"year":2024,"finding":"MAPL/MUL1 promotes SUMOylation of Drp1 in cardiomyocytes during sepsis; MAPL deficiency reduces Drp1 SUMOylation and Drp1 mitochondrial localization, ameliorating mitochondrial dysfunction and cardiac injury.","method":"Cardiomyocyte-specific MAPL KO mice, CLP sepsis model, SUMOylation assay, mitochondrial fractionation, membrane potential and ROS measurements","journal":"Journal of translational medicine","confidence":"Medium","confidence_rationale":"Tier 2 — tissue-specific KO with biochemical and functional readouts, single lab","pmids":["39529130"],"is_preprint":false},{"year":2024,"finding":"MUL1 SUMOylates HSPA9 at lysine 612, causing HSPA9 export from mitochondria to the nucleus where it interacts with SUZ12 and EZH2, leading to their ubiquitination-mediated degradation and downstream STAT3 pathway inhibition to suppress bladder cancer lymph node metastasis.","method":"Co-IP with LC-MS/MS, SUMOylation proteomics, K612R HSPA9 point mutation, mitochondrial dissociation assay, confocal microscopy, in vivo xenograft","journal":"International journal of biological sciences","confidence":"Medium","confidence_rationale":"Tier 2 — site-specific mutagenesis, Co-IP/MS, and in vivo validation, single lab","pmids":["39113711"],"is_preprint":false},{"year":2025,"finding":"MAPL/MUL1 induces pyroptosis through a pathway in which mitochondrial DNA is trafficked in mitochondrial-derived vesicles to lysosomes, which are permeabilized through gasdermin pores releasing mtDNA into the cytosol to activate cGAS; Parkinson's disease genes VPS35 and LRRK2 also regulate this MAPL-induced pyroptosis pathway.","method":"Genome-wide CRISPR functional screen, mtDNA trafficking assay, gasdermin pore assay, cGAS activation assay, primary macrophage depletion experiments","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 1-2 — genome-wide screen plus multiple orthogonal mechanistic assays including pathway epistasis","pmids":["41083601"],"is_preprint":false},{"year":2023,"finding":"MAPL loss in mice leads to increased bile acid production coupled with defective regulatory feedback; the peroxisomal bile acid transporter ABCD3 is a primary MAPL interacting partner and is SUMOylated in a MAPL-dependent manner.","method":"MAPL knockout mice, BioID proximity labeling, SUMOylation assay, primary hepatocyte cell-autonomous assays, metabolic profiling","journal":"EMBO reports","confidence":"Medium","confidence_rationale":"Tier 2 — KO model with BioID and SUMOylation assays, single lab","pmids":["37962001"],"is_preprint":false},{"year":2023,"finding":"MUL1 promotes degradation of cGAS by enhancing its interaction with MUL1 E3 ligase, a process mediated by HMGB1; GA disrupts HMGB1-cGAS interaction by inducing DOT1L-catalyzed methylation of HMGB1 at lysine 43, thereby promoting cGAS-MUL1 association and cGAS degradation.","method":"Co-immunoprecipitation, proteomics, pharmacological assays, scRNA-seq, ubiquitination assay","journal":"Journal of translational medicine","confidence":"Low","confidence_rationale":"Tier 3 — single lab Co-IP and functional assay, mechanistic detail partially indirect","pmids":["41998635"],"is_preprint":false},{"year":2025,"finding":"MUL1 ubiquitinates FUNDC1 to promote its proteasomal degradation, thereby reducing DRP1 expression and inhibiting DRP1-dependent mitophagy in cervical cancer cells.","method":"Co-immunoprecipitation, ubiquitination assay, MUL1 overexpression/knockdown, DRP1 knockdown rescue, xenograft model","journal":"Journal of molecular histology","confidence":"Low","confidence_rationale":"Tier 3 — Co-IP and ubiquitination assay in single lab, recent publication with no independent replication","pmids":["41697489"],"is_preprint":false},{"year":2025,"finding":"SLC44A2 promotes MUL1-mediated ubiquitination and degradation of carnitine palmitoyltransferase 2 (CPT2) by enhancing the physical interaction between MUL1 and CPT2, without altering MUL1 expression levels, thereby inhibiting mitochondrial fatty acid oxidation.","method":"Co-immunoprecipitation, ubiquitination assay, SLC44A2 KO/overexpression, metabolic assays, in vivo xenograft","journal":"Cell death & disease","confidence":"Low","confidence_rationale":"Tier 3 — Co-IP and ubiquitination in single recent study, no independent replication","pmids":["40592838"],"is_preprint":false},{"year":2023,"finding":"MUL1-mediated SUMOylation of NDP52 at lysine 262 via SUMO2 promotes recruitment of mitochondria to the autophagic pathway through early and recycling endosomal markers (EEA1, RAB11) and autophagy machinery components (ATG3, ATG5, ATG16L1, STX17), regulating mitophagy in cardiac hypertrophy.","method":"SUMOylation proteomics, isobaric quantitative proteomics, Co-IP with LC-MS/MS, NDP52 K262R point mutation, confocal microscopy, MUL1 overexpression","journal":"Journal of cellular physiology","confidence":"Medium","confidence_rationale":"Tier 2 — site-specific mutagenesis with orthogonal proteomics and imaging approaches, single lab","pmids":["37942585"],"is_preprint":false}],"current_model":"MUL1 (MULAN/MAPL/GIDE) is a mitochondrial outer membrane-anchored dual E3 ligase (ubiquitin and SUMO) whose cytosol-facing RING domain ubiquitinates substrates including Mitofusin 1/2, Akt, ULK1, UBXN7, HSPA5, FUNDC1, and CPT2 for proteasomal degradation, and SUMOylates substrates including Drp1, RIG-I, NDP52, HSPA9, and ABCD3 to regulate mitochondrial fission/fusion dynamics, ER-mitochondria contacts, mitophagy, antiviral innate immune signaling, NF-κB activation, apoptosis, pyroptosis, and cellular metabolism."},"narrative":{"teleology":[{"year":2008,"claim":"The identity of MUL1 as a mitochondrial outer membrane E3 ubiquitin ligase was established, resolving how a RING-domain protein anchored to mitochondria could influence both mitochondrial dynamics and NF-κB signaling.","evidence":"Ectopic expression, RNAi, domain mutagenesis, and subcellular fractionation in mammalian cells","pmids":["18213395","18591963"],"confidence":"High","gaps":["The endogenous substrates for MUL1 ubiquitin ligase activity were not identified","Mechanism linking MUL1 to NF-κB remained indirect","Whether MUL1 had ligase activities beyond ubiquitination was unknown"]},{"year":2009,"claim":"Discovery that MUL1 functions as the first mitochondria-anchored SUMO E3 ligase — SUMOylating DRP1 to stimulate fission — established its dual enzymatic identity and explained how mitochondrial fission is locally regulated.","evidence":"In vitro SUMOylation assays, RNAi, and co-immunoprecipitation","pmids":["19407830"],"confidence":"High","gaps":["How SUMOylation of DRP1 mechanistically promotes its mitochondrial recruitment was unclear","Whether SUMO1 vs SUMO2/3 specificity matters was not resolved"]},{"year":2012,"claim":"Identification of Akt as a direct ubiquitination substrate revealed MUL1's reach beyond mitochondrial dynamics into growth-factor signaling and cell survival pathways.","evidence":"In vitro and in vivo ubiquitination assays, reciprocal Co-IP, cell proliferation assays","pmids":["22410793"],"confidence":"High","gaps":["Which Akt isoform is preferentially targeted was not distinguished","Physiological context in which MUL1-Akt regulation is dominant was unknown"]},{"year":2014,"claim":"Genetic epistasis across Drosophila and mammals demonstrated that MUL1 ubiquitinates Mitofusin for proteasomal degradation in a pathway parallel to PINK1/Parkin, establishing functional redundancy in mitochondrial quality control.","evidence":"Drosophila double-mutant genetics, mouse cortical neuron assays, ubiquitination assays","pmids":["24898855"],"confidence":"High","gaps":["Whether MUL1 preferentially targets Mfn1 vs Mfn2 in different tissues was unresolved","Upstream signals activating MUL1 in the PINK1/Parkin-parallel pathway were unknown"]},{"year":2014,"claim":"Identification of MUL1's E2 partners (Ube2E2, Ube2E3, Ube2G2, Ube2L3) and an LIR motif in the RING domain linking MUL1-Ube2E3 to GABARAP provided the first molecular framework for how MUL1 connects ubiquitination to autophagy receptor engagement.","evidence":"Modified yeast two-hybrid, Co-IP, LIR mutagenesis","pmids":["25224329"],"confidence":"Medium","gaps":["LIR-GABARAP interaction not validated by structural methods","Functional contribution of each E2 to distinct substrate ubiquitination not determined","Omi/HtrA2 proteolytic regulation of MUL1 turnover identified in parallel but upstream triggers remain unclear"]},{"year":2015,"claim":"During apoptosis, MUL1-dependent DRP1 SUMOylation was shown to stabilize ER–mitochondria contact sites required for mitochondrial constriction, calcium flux, and cytochrome c release downstream of BAX/BAK, positioning MUL1 as an effector of the intrinsic apoptotic program.","evidence":"MAPL KO/KD, live ER-mitochondria imaging, SUMOylation and cytochrome c release assays","pmids":["26384664"],"confidence":"High","gaps":["How BAX/BAK activation signals to MUL1 was not elucidated","Whether MUL1 SUMOylation of DRP1 at ER-mitochondria contacts differs from bulk DRP1 SUMOylation was unknown"]},{"year":2016,"claim":"MUL1 and Parkin were shown to act redundantly in eliminating paternal mitochondria via mitophagy in mouse embryos, demonstrating a physiological requirement for MUL1 in uniparental mitochondrial inheritance.","evidence":"Double genetic KO of MUL1 and Parkin in mouse embryos, mitophagy flux assays","pmids":["27852436"],"confidence":"High","gaps":["Specific ubiquitination substrates mediating paternal mitophagy were not identified","Whether MUL1's SUMO ligase activity also contributes was untested"]},{"year":2017,"claim":"MUL1 was established as the SUMO E3 ligase for RIG-I, with SUMOylation shown to be a prerequisite for RIG-I activation and antiviral transcription; this resolved earlier observations linking MUL1 to innate immune signaling.","evidence":"MAPL KO in vivo and in vitro, BioID proximity labeling, constitutively active RIG-I epistasis","pmids":["28273895"],"confidence":"High","gaps":["Which SUMOylation sites on RIG-I are modified by MUL1 was not mapped","How MUL1 is recruited to RIG-I upon viral infection was unclear"]},{"year":2019,"claim":"Structural analysis of the MUL1 RING domain revealed a ββαβ fold with canonical cross-brace zinc coordination and direct binding to p53 transactivation domain, providing the first atomic-resolution view of substrate recognition by this ligase.","evidence":"NMR solution structure and chemical shift perturbation mapping","pmids":["31235254","35048531"],"confidence":"High","gaps":["Full-length MUL1 structure including transmembrane anchors remains undetermined","Whether p53 ubiquitination by MUL1 is physiologically significant in vivo is unknown"]},{"year":2019,"claim":"MUL1 KO in neurons demonstrated that MUL1 antagonizes Mfn2-mediated ER-mitochondria tethering; loss of MUL1 elevates Mfn2, disrupts ER-mitochondria calcium coupling, and paradoxically triggers calcineurin-dependent DRP1 activation and Parkin-mediated mitophagy.","evidence":"MUL1 KO neurons, live imaging of ER-mitochondria contacts, calcium measurements, Mfn2 overexpression phenocopy, calcineurin inhibition","pmids":["31409786"],"confidence":"High","gaps":["Whether this feedback loop operates in non-neuronal cells was not tested","Direct calcineurin-DRP1 dephosphorylation in this context was not biochemically reconstituted"]},{"year":2020,"claim":"Identification of UBXN7 and Akt2/HIF-1α as MUL1 ubiquitination substrates established that MUL1 regulates the metabolic switch between oxidative phosphorylation and glycolysis by controlling HIF-1α stability through multiple converging mechanisms.","evidence":"MUL1 KO cells, metabolic flux analysis, ubiquitination assays, metabolomics/lipidomics","pmids":["32005965","35846359"],"confidence":"Medium","gaps":["Whether MUL1 directly ubiquitinates HIF-1α or only indirectly controls it via UBXN7/Akt2 was not fully resolved","Tissue-specific metabolic consequences in vivo not characterized"]},{"year":2023,"claim":"Expansion of MUL1's SUMO substrate repertoire to include NDP52 (mitophagy receptor) and ABCD3 (peroxisomal transporter) showed that MUL1 SUMOylation regulates organelle-specific processes beyond mitochondria, including peroxisomal bile acid metabolism and endosome-mediated mitophagy.","evidence":"SUMOylation proteomics, site-specific mutagenesis (NDP52 K262R), BioID, MAPL KO mice with metabolic profiling","pmids":["37942585","37962001"],"confidence":"Medium","gaps":["How MUL1 on the mitochondrial outer membrane accesses peroxisomal ABCD3 is mechanistically unclear","Whether NDP52 SUMOylation is required for mitophagy in vivo has not been tested"]},{"year":2025,"claim":"A genome-wide CRISPR screen revealed that MUL1 induces pyroptosis by directing mitochondrial DNA through mitochondrial-derived vesicles to lysosomes, which are permeabilized by gasdermin pores to release mtDNA into the cytosol for cGAS activation — linking MUL1 to Parkinson's disease genes VPS35 and LRRK2.","evidence":"Genome-wide CRISPR screen, mtDNA trafficking assays, gasdermin pore assays, cGAS activation, primary macrophage experiments","pmids":["41083601"],"confidence":"High","gaps":["The direct MUL1 substrate(s) initiating mitochondrial-derived vesicle formation for this pathway are unknown","Whether MUL1-driven pyroptosis contributes to neurodegeneration in Parkinson's disease models has not been tested"]},{"year":null,"claim":"A full-length structural model of MUL1 including its transmembrane domains and the basis for substrate selectivity between ubiquitination and SUMOylation remain unresolved; how upstream signals dynamically regulate MUL1 activity and its partitioning between dual ligase functions is unknown.","evidence":"","pmids":[],"confidence":"Low","gaps":["No full-length structure of MUL1 including transmembrane domains exists","Mechanism by which MUL1 switches between ubiquitin and SUMO E3 ligase activities is unknown","Upstream regulatory signals controlling MUL1 enzymatic activity under physiological conditions are largely uncharacterized"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,1,2,3,5,7,13,16,17,19,26,27,28]},{"term_id":"GO:0016874","term_label":"ligase activity","supporting_discovery_ids":[0,3,5,13,17]}],"localization":[{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[0,1,4,6,14]}],"pathway":[{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[6,7,8,28]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[2,4,23]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[10,11]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[17,19,24]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,5,12]},{"term_id":"R-HSA-1852241","term_label":"Organelle biogenesis and maintenance","supporting_discovery_ids":[1,3,14,20,21]}],"complexes":[],"partners":["DRP1","MFN2","AKT1","RIG-I","UBXN7","NDP52","TRAF2","ABCD3"],"other_free_text":[]},"mechanistic_narrative":"MUL1 is a mitochondrial outer membrane-anchored dual E3 ligase that uses its cytosol-facing RING finger domain to catalyze both ubiquitination and SUMOylation of diverse substrates, thereby coordinating mitochondrial dynamics, mitophagy, apoptosis, innate immune signaling, and cellular metabolism. As a ubiquitin E3 ligase, MUL1 K48-polyubiquitinates Mitofusin 1/2, Akt, ULK1, UBXN7, HSPA5, and HIF-1α for proteasomal degradation, functioning in parallel with the PINK1/Parkin pathway to maintain mitochondrial integrity and regulate the balance between oxidative phosphorylation and glycolysis [PMID:24898855, PMID:22410793, PMID:32005965, PMID:35846359]. As a SUMO E3 ligase, MUL1 SUMOylates DRP1 to promote mitochondrial fission and stabilize ER–mitochondria contact sites during apoptosis, SUMOylates RIG-I to enable antiviral innate immune activation, and SUMOylates NDP52 and ABCD3 to regulate mitophagy and peroxisomal bile acid transport, respectively [PMID:19407830, PMID:26384664, PMID:28273895, PMID:37942585, PMID:37962001]. MUL1 also drives pyroptosis through a pathway in which mitochondrial DNA is trafficked via mitochondrial-derived vesicles to lysosomes, permeabilized through gasdermin pores, and released into the cytosol to activate cGAS [PMID:41083601]."},"prefetch_data":{"uniprot":{"accession":"Q969V5","full_name":"Mitochondrial ubiquitin ligase activator of NFKB 1","aliases":["E3 SUMO-protein ligase MUL1","E3 ubiquitin-protein ligase MUL1","Growth inhibition and death E3 ligase","Mitochondrial-anchored protein ligase","Protein Hades","Putative NF-kappa-B-activating protein 266","RING finger protein 218","RING-type E3 ubiquitin transferase NFKB 1"],"length_aa":352,"mass_kda":39.8,"function":"Exhibits weak E3 ubiquitin-protein ligase activity (PubMed:18591963, PubMed:19407830, PubMed:22410793). E3 ubiquitin ligases accept ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfer the ubiquitin to targeted substrates (PubMed:18591963, PubMed:19407830, PubMed:22410793). Can ubiquitinate AKT1 preferentially at 'Lys-284' involving 'Lys-48'-linked polyubiquitination and seems to be involved in regulation of Akt signaling by targeting phosphorylated Akt to proteasomal degradation (PubMed:22410793). Mediates polyubiquitination of cytoplasmic TP53 at 'Lys-24' which targets TP53 for proteasomal degradation, thus reducing TP53 levels in the cytoplasm and mitochondrion (PubMed:21597459). Proposed to preferentially act as a SUMO E3 ligase at physiological concentrations (PubMed:19407830). Plays a role in the control of mitochondrial morphology by promoting mitochondrial fragmentation, and influences mitochondrial localization (PubMed:18207745, PubMed:18213395, PubMed:19407830). Likely to promote mitochondrial fission through negatively regulating the mitochondrial fusion proteins MFN1 and MFN2, acting in a pathway that is parallel to the PRKN/PINK1 regulatory pathway (PubMed:24898855). May also be involved in the sumoylation of the membrane fission protein DNM1L (PubMed:18207745, PubMed:19407830). Inhibits cell growth (PubMed:18591963, PubMed:22410793). When overexpressed, activates JNK through MAP3K7/TAK1 and induces caspase-dependent apoptosis (PubMed:23399697). Involved in the modulation of innate immune defense against viruses by inhibiting RIGI-dependent antiviral response (PubMed:23399697). Can mediate RIGI sumoylation and disrupt its polyubiquitination (PubMed:23399697)","subcellular_location":"Mitochondrion outer membrane; Peroxisome","url":"https://www.uniprot.org/uniprotkb/Q969V5/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/MUL1","classification":"Not Classified","n_dependent_lines":8,"n_total_lines":1208,"dependency_fraction":0.006622516556291391},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/MUL1","total_profiled":1310},"omim":[{"mim_id":"621246","title":"TRAB DOMAIN-CONTAINING PROTEIN; TRABD","url":"https://www.omim.org/entry/621246"},{"mim_id":"612037","title":"MITOCHONDRIAL UBIQUITIN LIGASE ACTIVATOR OF NFKB 1; MUL1","url":"https://www.omim.org/entry/612037"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"},{"location":"Mitochondria","reliability":"Approved"},{"location":"Cytosol","reliability":"Approved"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/MUL1"},"hgnc":{"alias_symbol":["FLJ12875","MULAN","RNF218","MAPL","GIDE"],"prev_symbol":["C1orf166"]},"alphafold":{"accession":"Q969V5","domains":[{"cath_id":"-","chopping":"45-224","consensus_level":"high","plddt":91.464,"start":45,"end":224},{"cath_id":"3.30.40.10","chopping":"295-347","consensus_level":"high","plddt":88.33,"start":295,"end":347},{"cath_id":"1.10.287","chopping":"8-41_225-289","consensus_level":"medium","plddt":91.858,"start":8,"end":289}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q969V5","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q969V5-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q969V5-F1-predicted_aligned_error_v6.png","plddt_mean":89.88},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=MUL1","jax_strain_url":"https://www.jax.org/strain/search?query=MUL1"},"sequence":{"accession":"Q969V5","fasta_url":"https://rest.uniprot.org/uniprotkb/Q969V5.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q969V5/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q969V5"}},"corpus_meta":[{"pmid":"18213395","id":"PMC_18213395","title":"Genome-wide and functional annotation of human E3 ubiquitin ligases identifies MULAN, a mitochondrial E3 that regulates the organelle's dynamics and signaling.","date":"2008","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/18213395","citation_count":641,"is_preprint":false},{"pmid":"19407830","id":"PMC_19407830","title":"MAPL is a new mitochondrial SUMO E3 ligase that regulates mitochondrial fission.","date":"2009","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/19407830","citation_count":284,"is_preprint":false},{"pmid":"27852436","id":"PMC_27852436","title":"Elimination of paternal mitochondria in mouse embryos occurs through autophagic degradation dependent on PARKIN and MUL1.","date":"2016","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/27852436","citation_count":275,"is_preprint":false},{"pmid":"26384664","id":"PMC_26384664","title":"MAPL SUMOylation of Drp1 Stabilizes an ER/Mitochondrial Platform Required for Cell Death.","date":"2015","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/26384664","citation_count":272,"is_preprint":false},{"pmid":"24898855","id":"PMC_24898855","title":"MUL1 acts in parallel to the PINK1/parkin pathway in regulating mitofusin and compensates for loss of PINK1/parkin.","date":"2014","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/24898855","citation_count":263,"is_preprint":false},{"pmid":"15590941","id":"PMC_15590941","title":"Mulan: multiple-sequence local alignment and visualization for studying function and evolution.","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15590941","citation_count":195,"is_preprint":false},{"pmid":"23140641","id":"PMC_23140641","title":"The ubiquitin ligase Mul1 induces mitophagy in skeletal muscle in response to muscle-wasting stimuli.","date":"2012","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/23140641","citation_count":130,"is_preprint":false},{"pmid":"26018823","id":"PMC_26018823","title":"Mitochondrial outer-membrane E3 ligase MUL1 ubiquitinates ULK1 and regulates selenite-induced mitophagy.","date":"2015","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/26018823","citation_count":128,"is_preprint":false},{"pmid":"31409786","id":"PMC_31409786","title":"Mul1 restrains Parkin-mediated mitophagy in mature neurons by maintaining ER-mitochondrial contacts.","date":"2019","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/31409786","citation_count":125,"is_preprint":false},{"pmid":"22410793","id":"PMC_22410793","title":"Akt is negatively regulated by the MULAN E3 ligase.","date":"2012","source":"Cell research","url":"https://pubmed.ncbi.nlm.nih.gov/22410793","citation_count":93,"is_preprint":false},{"pmid":"25224329","id":"PMC_25224329","title":"Mulan E3 ubiquitin ligase interacts with multiple E2 conjugating enzymes and participates in mitophagy by recruiting GABARAP.","date":"2014","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/25224329","citation_count":71,"is_preprint":false},{"pmid":"27064726","id":"PMC_27064726","title":"Melatonin rescues zebrafish embryos from the parkinsonian phenotype restoring the parkin/PINK1/DJ-1/MUL1 network.","date":"2016","source":"Journal of pineal research","url":"https://pubmed.ncbi.nlm.nih.gov/27064726","citation_count":71,"is_preprint":false},{"pmid":"29260979","id":"PMC_29260979","title":"HSPA5 negatively regulates lysosomal activity through ubiquitination of MUL1 in head and neck cancer.","date":"2018","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/29260979","citation_count":69,"is_preprint":false},{"pmid":"18591963","id":"PMC_18591963","title":"GIDE is a mitochondrial E3 ubiquitin ligase that induces apoptosis and slows growth.","date":"2008","source":"Cell research","url":"https://pubmed.ncbi.nlm.nih.gov/18591963","citation_count":68,"is_preprint":false},{"pmid":"24709290","id":"PMC_24709290","title":"Inactivation of Omi/HtrA2 protease leads to the deregulation of mitochondrial Mulan E3 ubiquitin ligase and increased mitophagy.","date":"2014","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/24709290","citation_count":57,"is_preprint":false},{"pmid":"34140641","id":"PMC_34140641","title":"The HSF1/miR-135b-5p axis induces protective autophagy to promote oxaliplatin resistance through the MUL1/ULK1 pathway in colorectal cancer.","date":"2021","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/34140641","citation_count":57,"is_preprint":false},{"pmid":"26450902","id":"PMC_26450902","title":"Non-thermal plasma induces AKT degradation through turn-on the MUL1 E3 ligase in head and neck cancer.","date":"2015","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/26450902","citation_count":50,"is_preprint":false},{"pmid":"24841215","id":"PMC_24841215","title":"Mitochondrial hyperfusion promotes NF-κB activation via the mitochondrial E3 ligase MULAN.","date":"2014","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/24841215","citation_count":49,"is_preprint":false},{"pmid":"32001742","id":"PMC_32001742","title":"Gemcitabine induces Parkin-independent mitophagy through mitochondrial-resident E3 ligase MUL1-mediated stabilization of PINK1.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/32001742","citation_count":46,"is_preprint":false},{"pmid":"21083857","id":"PMC_21083857","title":"Molecular analysis of parasitoid linkages (MAPL): gut contents of adult parasitoid wasps reveal larval host.","date":"2010","source":"Molecular ecology","url":"https://pubmed.ncbi.nlm.nih.gov/21083857","citation_count":46,"is_preprint":false},{"pmid":"23399697","id":"PMC_23399697","title":"Mitochondrially localised MUL1 is a novel modulator of antiviral signaling.","date":"2013","source":"Immunology and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/23399697","citation_count":40,"is_preprint":false},{"pmid":"37489753","id":"PMC_37489753","title":"MuLan-Methyl-multiple transformer-based language models for accurate DNA methylation prediction.","date":"2023","source":"GigaScience","url":"https://pubmed.ncbi.nlm.nih.gov/37489753","citation_count":32,"is_preprint":false},{"pmid":"37252276","id":"PMC_37252276","title":"Ginsenoside compound K protects against cerebral ischemia/reperfusion injury via Mul1/Mfn2-mediated mitochondrial dynamics and bioenergy.","date":"2022","source":"Journal of ginseng research","url":"https://pubmed.ncbi.nlm.nih.gov/37252276","citation_count":32,"is_preprint":false},{"pmid":"31679452","id":"PMC_31679452","title":"Defending stressed mitochondria: uncovering the role of MUL1 in suppressing neuronal mitophagy.","date":"2019","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/31679452","citation_count":26,"is_preprint":false},{"pmid":"28273895","id":"PMC_28273895","title":"The dynamic interacting landscape of MAPL reveals essential functions for SUMOylation in innate immunity.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28273895","citation_count":26,"is_preprint":false},{"pmid":"32005965","id":"PMC_32005965","title":"Mitochondrial MUL1 E3 ubiquitin ligase regulates Hypoxia Inducible Factor (HIF-1α) and metabolic reprogramming by modulating the UBXN7 cofactor protein.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/32005965","citation_count":24,"is_preprint":false},{"pmid":"35638168","id":"PMC_35638168","title":"Mitochondrial E3 ubiquitin ligase 1 (MUL1) as a novel therapeutic target for diseases associated with mitochondrial dysfunction.","date":"2022","source":"IUBMB life","url":"https://pubmed.ncbi.nlm.nih.gov/35638168","citation_count":23,"is_preprint":false},{"pmid":"31138137","id":"PMC_31138137","title":"Effects of MUL1 and PARKIN on the circadian clock, brain and behaviour in Drosophila Parkinson's disease models.","date":"2019","source":"BMC neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/31138137","citation_count":19,"is_preprint":false},{"pmid":"29299162","id":"PMC_29299162","title":"FOXO3 induces ubiquitylation of AKT through MUL1 regulation.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/29299162","citation_count":17,"is_preprint":false},{"pmid":"30716316","id":"PMC_30716316","title":"Natural compound methyl protodioscin protects rat brain from ischemia/reperfusion injury through regulation of Mul1/SOD2 pathway.","date":"2019","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/30716316","citation_count":14,"is_preprint":false},{"pmid":"35846359","id":"PMC_35846359","title":"Regulation of Metabolism by Mitochondrial MUL1 E3 Ubiquitin Ligase.","date":"2022","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/35846359","citation_count":13,"is_preprint":false},{"pmid":"30816444","id":"PMC_30816444","title":"MUL1 E3 ligase regulates the antitumor effects of metformin in chemoresistant ovarian cancer cells via AKT degradation.","date":"2019","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/30816444","citation_count":13,"is_preprint":false},{"pmid":"36531208","id":"PMC_36531208","title":"Inhibition of Prostaglandin E2 Receptor EP3 Attenuates Oxidative Stress and Neuronal Apoptosis Partially by Modulating p38MAPK/FOXO3/Mul1/Mfn2 Pathway after Subarachnoid Hemorrhage in Rats.","date":"2022","source":"Oxidative medicine and cellular longevity","url":"https://pubmed.ncbi.nlm.nih.gov/36531208","citation_count":13,"is_preprint":false},{"pmid":"25169519","id":"PMC_25169519","title":"C13orf18 and C1orf166 (MULAN) DNA genes methylation are not associated with cervical cancer and precancerous lesions of human papillomavirus genotypes in Iranian women.","date":"2014","source":"Asian Pacific journal of cancer prevention : APJCP","url":"https://pubmed.ncbi.nlm.nih.gov/25169519","citation_count":13,"is_preprint":false},{"pmid":"22967128","id":"PMC_22967128","title":"Innate immune genes including a mucin-like gene, mul-1, induced by ionizing radiation in Caenorhabditis elegans.","date":"2012","source":"Radiation research","url":"https://pubmed.ncbi.nlm.nih.gov/22967128","citation_count":12,"is_preprint":false},{"pmid":"37942585","id":"PMC_37942585","title":"NDP52 SUMOylation contributes to low-dose X-rays-induced cardiac hypertrophy through PINK1/Parkin-mediated mitophagy via MUL1/SUMO2 signalling.","date":"2023","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/37942585","citation_count":11,"is_preprint":false},{"pmid":"39113711","id":"PMC_39113711","title":"SUMO E3 ligase MUL1 inhibits lymph node metastasis of bladder cancer by mediating mitochondrial HSPA9 translocation.","date":"2024","source":"International journal of biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/39113711","citation_count":10,"is_preprint":false},{"pmid":"31235254","id":"PMC_31235254","title":"Solution structure of MUL1-RING domain and its interaction with p53 transactivation domain.","date":"2019","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/31235254","citation_count":9,"is_preprint":false},{"pmid":"35048531","id":"PMC_35048531","title":"MUL1-RING recruits the substrate, p53-TAD as a complex with UBE2D2-UB conjugate.","date":"2022","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/35048531","citation_count":8,"is_preprint":false},{"pmid":"23140636","id":"PMC_23140636","title":"The missing link: Mul1 signals mitophagy and muscle wasting.","date":"2012","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/23140636","citation_count":8,"is_preprint":false},{"pmid":"33116527","id":"PMC_33116527","title":"NR4A2 Exacerbates Cerebral Ischemic Brain Injury via Modulating microRNA-652/Mul1 Pathway.","date":"2020","source":"Neuropsychiatric disease and treatment","url":"https://pubmed.ncbi.nlm.nih.gov/33116527","citation_count":7,"is_preprint":false},{"pmid":"37962001","id":"PMC_37962001","title":"MAPL loss dysregulates bile and liver metabolism in mice.","date":"2023","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/37962001","citation_count":6,"is_preprint":false},{"pmid":"36260939","id":"PMC_36260939","title":"Influence of melatonin associated with the Bio-Gide® membrane on osteoblast activity: an in vitro Study.","date":"2022","source":"Acta odontologica latinoamericana : AOL","url":"https://pubmed.ncbi.nlm.nih.gov/36260939","citation_count":6,"is_preprint":false},{"pmid":"39529130","id":"PMC_39529130","title":"Deletion of MAPL ameliorates septic cardiomyopathy by mitigating mitochondrial dysfunction.","date":"2024","source":"Journal of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/39529130","citation_count":5,"is_preprint":false},{"pmid":"30793286","id":"PMC_30793286","title":"MUL1 gene polymorphisms and Parkinson's disease risk.","date":"2019","source":"Acta neurologica Scandinavica","url":"https://pubmed.ncbi.nlm.nih.gov/30793286","citation_count":5,"is_preprint":false},{"pmid":"41083601","id":"PMC_41083601","title":"MAPL regulates gasdermin-mediated release of mtDNA from lysosomes to drive pyroptotic cell death.","date":"2025","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/41083601","citation_count":5,"is_preprint":false},{"pmid":"37051468","id":"PMC_37051468","title":"Myristate induces mitochondrial fragmentation and cardiomyocyte hypertrophy through mitochondrial E3 ubiquitin ligase MUL1.","date":"2023","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/37051468","citation_count":5,"is_preprint":false},{"pmid":"22056942","id":"PMC_22056942","title":"Cloning and expression analysis of the mitochondrial ubiquitin ligase activator of NF-κB (MULAN) in Atlantic salmon (Salmo salar).","date":"2011","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/22056942","citation_count":5,"is_preprint":false},{"pmid":"40796734","id":"PMC_40796734","title":"The mitochondrial E3 ligase MAPL SUMOylates Drp1 to facilitate mitochondrial fission in intervertebral disc degeneration.","date":"2025","source":"Bone research","url":"https://pubmed.ncbi.nlm.nih.gov/40796734","citation_count":5,"is_preprint":false},{"pmid":"26047467","id":"PMC_26047467","title":"The Evolutionary History of MAPL (Mitochondria-Associated Protein Ligase) and Other Eukaryotic BAM/GIDE Domain Proteins.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26047467","citation_count":5,"is_preprint":false},{"pmid":"22989998","id":"PMC_22989998","title":"MULAN related gene (MRG): a potential novel ubiquitin ligase activator of NF-kB involved in immune response in Atlantic salmon (Salmo salar).","date":"2012","source":"Developmental and comparative immunology","url":"https://pubmed.ncbi.nlm.nih.gov/22989998","citation_count":5,"is_preprint":false},{"pmid":"40592838","id":"PMC_40592838","title":"SLC44A2 negatively regulates mitochondrial fatty acid oxidation to suppress colorectal progression by blocking the MUL1-CPT2 interaction.","date":"2025","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/40592838","citation_count":4,"is_preprint":false},{"pmid":"38725872","id":"PMC_38725872","title":"Inactivation of mitochondrial MUL1 E3 ubiquitin ligase deregulates mitophagy and prevents diet-induced obesity in mice.","date":"2024","source":"Frontiers in molecular biosciences","url":"https://pubmed.ncbi.nlm.nih.gov/38725872","citation_count":4,"is_preprint":false},{"pmid":"19578480","id":"PMC_19578480","title":"MICROPATTERNING OF GOLD SUBSTRATES BASED ON POLY(PROPYLENE SULFIDE-BL-ETHYLENE GLYCOL), (PPS-PEG) BACKGROUND PASSIVATION AND THE MOLECULAR-ASSEMBLY PATTERNING BY LIFT-OFF (MAPL) TECHNIQUE.","date":"2008","source":"Surface science","url":"https://pubmed.ncbi.nlm.nih.gov/19578480","citation_count":4,"is_preprint":false},{"pmid":"40989496","id":"PMC_40989496","title":"MULAN: multimodal protein language model for sequence and structure encoding.","date":"2025","source":"Bioinformatics advances","url":"https://pubmed.ncbi.nlm.nih.gov/40989496","citation_count":2,"is_preprint":false},{"pmid":"39134101","id":"PMC_39134101","title":"MUL1 identified as mitochondria-linked biomarker promoting cisplatin resistance in OC cells.","date":"2024","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/39134101","citation_count":2,"is_preprint":false},{"pmid":"38639871","id":"PMC_38639871","title":"Increased ROS levels in mitochondrial outer membrane protein Mul1-deficient oocytes result in abnormal preimplantation embryogenesis.","date":"2024","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/38639871","citation_count":1,"is_preprint":false},{"pmid":"26973995","id":"PMC_26973995","title":"Retraction Notice to: The Ubiquitin Ligase Mul1 Induces Mitophagy in Skeletal Muscle in Response to Muscle-Wasting Stimuli.","date":"2015","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/26973995","citation_count":1,"is_preprint":false},{"pmid":"41468924","id":"PMC_41468924","title":"The tumor suppressor role of mitochondrial E3 ubiquitin ligase MUL1 in osteosarcoma.","date":"2025","source":"Biochimica et biophysica acta. Molecular cell research","url":"https://pubmed.ncbi.nlm.nih.gov/41468924","citation_count":0,"is_preprint":false},{"pmid":"41697489","id":"PMC_41697489","title":"MUL1 suppresses cervical cancer progression by targeting FUNDC1 for ubiquitination and inhibiting DRP1-dependent mitophagy.","date":"2026","source":"Journal of molecular histology","url":"https://pubmed.ncbi.nlm.nih.gov/41697489","citation_count":0,"is_preprint":false},{"pmid":"38088487","id":"PMC_38088487","title":"Retraction: Protective effect of hsa-miR-570-3p targeting CD274 on triple negative breast cancer by blocking PI3K/AKT/mTOR signaling pathway. Li-Li Wang, Wei-Wei Huang, Jing Huang, Rong-Fang Huang, Na-Ni Li, Yi Hong, Mu-Lan Chen, Fan Wu, Jian Liu, Kaohsiung J Med Sci. 2020; 36(8): 581-591 (https://doi.org/10.1002/kjm2.12212).","date":"2023","source":"The Kaohsiung journal of medical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/38088487","citation_count":0,"is_preprint":false},{"pmid":"41944736","id":"PMC_41944736","title":"Glypican-3 Upregulated by YTHDF1 in an m6A-Dependent Manner Interacts With MUL1 to Repress HSF1 Ubiquitination Degradation, Boost CD276 Transcription, and Mediate Immune Escape in Gastric Cancer.","date":"2026","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/41944736","citation_count":0,"is_preprint":false},{"pmid":"41998635","id":"PMC_41998635","title":"18-β-glycyrrhetinic acid facilitates nuclear-mitochondrial communications to alleviate oxidative stress through HMGB1-cGAS-Mul1 axis in tendinopathy.","date":"2026","source":"Journal of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/41998635","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2024.08.24.609515","title":"MuLAN: Mutation-driven Light Attention Networks for investigating protein-protein interactions from sequences","date":"2024-08-26","source":"bioRxiv","url":"https://doi.org/10.1101/2024.08.24.609515","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":31402,"output_tokens":6462,"usd":0.095568},"stage2":{"model":"claude-opus-4-6","input_tokens":10168,"output_tokens":3871,"usd":0.221422},"total_usd":0.31699,"stage1_batch_id":"msgbatch_012ZiiCUBfB62NCTQd4Bk1Jo","stage2_batch_id":"msgbatch_01Xuqq9aUHoQouS7UVGZNStZ","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2008,\n      \"finding\": \"MULAN/MUL1 is a mitochondrial outer membrane protein with two transmembrane domains mediating localization and a C-terminal RING finger domain exposed to the cytosol that confers E3 ubiquitin ligase activity; both intact RING finger and correct subcellular localization are required for regulation of mitochondrial dynamics and NF-κB activation.\",\n      \"method\": \"Ectopic expression and RNAi knockdown with imaging, domain mutagenesis, subcellular fractionation\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (imaging, RNAi, mutagenesis) in foundational discovery paper with >600 citations\",\n      \"pmids\": [\"18213395\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"MAPL/MUL1 functions as the first mitochondria-anchored SUMO E3 ligase; it SUMOylates DRP1 to stimulate mitochondrial fission.\",\n      \"method\": \"Biochemical SUMOylation assays, overexpression and RNAi knockdown, co-immunoprecipitation\",\n      \"journal\": \"EMBO reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro biochemical assay combined with RNAi and overexpression, >280 citations\",\n      \"pmids\": [\"19407830\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"GIDE/MUL1 induces apoptosis via caspase activation and JNK-dependent cytochrome c and Smac release; the pro-apoptotic activity requires its E3 ubiquitin ligase (RING finger) activity.\",\n      \"method\": \"Overexpression, caspase inhibitor treatment, dominant-negative caspase-9, JNK inhibition, RING finger mutagenesis\",\n      \"journal\": \"Cell research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal functional assays with mutagenesis confirming enzymatic requirement\",\n      \"pmids\": [\"18591963\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"MUL1 acts in parallel to the PINK1/parkin pathway by ubiquitinating Mitofusin (Mfn) to target it for proteasomal degradation, thereby maintaining mitochondrial integrity; MUL1 suppresses PINK1 or parkin mutant phenotypes in Drosophila and compensates for their loss in mammals.\",\n      \"method\": \"Drosophila genetic epistasis, loss-of-function double mutants, mouse cortical neuron degeneration assay, ubiquitination assay\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — genetic epistasis across two species plus biochemical ubiquitination assay, >260 citations\",\n      \"pmids\": [\"24898855\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"During apoptosis, MAPL/MUL1-dependent SUMOylation of Drp1 stabilizes ER/mitochondrial contact sites required for mitochondrial constriction, calcium flux, cristae remodeling, and cytochrome c release; MAPL acts downstream of BAX/BAK activation.\",\n      \"method\": \"MAPL knockout/knockdown, SUMOylation assay, live imaging of ER-mitochondria contacts, cytochrome c release assay, BAX/BAK oligomer analysis\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods including KO, biochemical assays, and live imaging; >270 citations\",\n      \"pmids\": [\"26384664\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"MULAN/MUL1 negatively regulates Akt by directly interacting with and ubiquitinating phosphorylated Akt, leading to its proteasomal degradation and suppression of cell proliferation and viability.\",\n      \"method\": \"Co-immunoprecipitation, in vitro ubiquitination assay, in vivo ubiquitination assay, cell proliferation/viability assays\",\n      \"journal\": \"Cell research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro and in vivo ubiquitination with reciprocal Co-IP and functional readout\",\n      \"pmids\": [\"22410793\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"MUL1 and PARKIN play redundant roles in elimination of paternal mitochondria via mitophagy in mouse embryos; the process requires mitochondrial depolarization, FIS1, P62, and PINK1 kinase.\",\n      \"method\": \"Mouse embryo mitophagy assay, autophagosome/lysosome tracking, genetic knockouts of PARKIN and MUL1, pre-implantation embryo culture\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO combined with live imaging and functional mitophagy readout in physiologically relevant embryo model; >275 citations\",\n      \"pmids\": [\"27852436\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"MUL1 ubiquitinates ULK1 (a key autophagy kinase) which partially translocates to mitochondria after selenite treatment, providing a mechanism for MUL1-regulated mitophagy.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, subcellular fractionation, ULK1/ATG5 knockdown\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP and ubiquitination assay in single study\",\n      \"pmids\": [\"26018823\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"MUL1 E3 ligase interacts with four E2 ubiquitin-conjugating enzymes (Ube2E2, Ube2E3, Ube2G2, Ube2L3); the MUL1-Ube2E3 complex recruits GABARAP via an LC3-interacting region (LIR) in the MUL1 RING domain, linking MUL1 to mitophagy.\",\n      \"method\": \"Modified yeast two-hybrid screen with MUL1-E2 fusion proteins, Co-IP, LIR mutagenesis\",\n      \"journal\": \"Cellular signalling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — yeast two-hybrid plus Co-IP, single lab study\",\n      \"pmids\": [\"25224329\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Omi/HtrA2 mitochondrial serine protease degrades Mulan/MUL1 as a specific substrate during oxidative stress; loss of Omi/HtrA2 protease activity causes MUL1 accumulation, decreased Mfn2 levels, and increased mitophagy.\",\n      \"method\": \"Substrate identification by protease assay, Omi/HtrA2 knockout MEFs and mnd2 mouse tissues, immunoblotting for Mfn2 and mitophagy markers\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO model plus biochemical protease-substrate relationship, single lab\",\n      \"pmids\": [\"24709290\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"MUL1 localizes to mitochondria where it interacts with MAVS and catalyzes post-translational modifications of RIG-I that inhibit RIG-I-dependent NF-κB and IFN-β signaling; MUL1 depletion potentiates antiviral responses.\",\n      \"method\": \"Co-immunoprecipitation (MUL1-MAVS, MUL1-RIG-I), RNAi knockdown, NF-κB and IFN-β reporter assays, Sendai virus/poly I:C challenge\",\n      \"journal\": \"Immunology and cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — Co-IP with functional reporter assays in single study\",\n      \"pmids\": [\"23399697\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"MAPL/MUL1 is required for SUMOylation of RIG-I upon Sendai virus infection; RIG-I SUMOylation is a prerequisite for RIG-I activation and antiviral gene transcription. A constitutively active RIG-I bypasses the MAPL requirement.\",\n      \"method\": \"MAPL knockout (in vivo and in vitro), BioID proximity labeling, SUMOylation assay, constitutively active RIG-I epistasis\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO genetics with BioID interactome and epistasis showing MAPL acts upstream of RIG-I activation\",\n      \"pmids\": [\"28273895\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Mitochondrial hyperfusion promotes NF-κB activation through MULAN/MUL1 in a RING domain-dependent manner; MULAN forms a complex with TRAF2 and modulates its ubiquitylation as a transmitter of NF-κB signaling.\",\n      \"method\": \"Dominant-negative Drp1 overexpression, MARCH5 overexpression, MULAN knockdown, Co-IP of MULAN-TRAF2, NF-κB reporter assay\",\n      \"journal\": \"The FEBS journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — Co-IP and functional reporter with RNAi, single lab study\",\n      \"pmids\": [\"24841215\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"MUL1 ubiquitinates HSPA5/GRP78 via K48-linked ubiquitination at lysine 446, leading to HSPA5 degradation and consequent lysosomal inhibition in head and neck cancer cells.\",\n      \"method\": \"Co-immunoprecipitation, K48-linked ubiquitination assay with K446 site mutation, MUL1 CRISPR knockout, Western blot\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — site-specific mutagenesis of ubiquitination site plus KO validation, single lab\",\n      \"pmids\": [\"29260979\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"MUL1 deficiency increases Mfn2 activity, triggering mitochondrial hyperfusion and acting as an ER-mitochondria tethering antagonist; reduced ER-Mito coupling elevates cytoplasmic Ca2+ which activates calcineurin and induces Drp1-dependent mitochondrial fragmentation and Parkin-mediated mitophagy. Overexpressing Mfn2 (not Mfn1) phenocopies MUL1 deficiency.\",\n      \"method\": \"MUL1 knockout neurons, live imaging of ER-Mito contacts, Ca2+ measurements, Mfn2 overexpression, PTPIP51 rescue, calcineurin inhibition\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (KO, live imaging, Ca2+ measurements, rescue experiments) in single rigorous study\",\n      \"pmids\": [\"31409786\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"The MUL1 RING domain adopts a ββαβ fold with a canonical cross-brace zinc-coordination motif; it interacts directly with the p53 transactivation domain 2 subdomain (residues 39-57) as determined by NMR chemical shift perturbation.\",\n      \"method\": \"NMR solution structure determination, NMR chemical shift perturbation experiments\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — NMR structure with binding site mapping\",\n      \"pmids\": [\"31235254\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"The MUL1 RING domain recruits both UBE2D2 and its substrate p53-TAD simultaneously; RING binding induces closed conformation of UBE2D2~Ub, and substrate binding affinity to the RING:UBE2D2~Ub complex is enhanced compared to either alone, explaining ubiquitylation of intrinsically disordered p53-TAD.\",\n      \"method\": \"Complex structure determination, oxyester mimetic UBE2D2~Ub assays, mutagenesis (N77A, S22R/C85S), binding affinity measurements\",\n      \"journal\": \"The FEBS journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — structural and biochemical reconstitution with mutagenesis\",\n      \"pmids\": [\"35048531\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"MUL1 ubiquitinates UBXN7 (cofactor of the CRL2VHL ligase complex) via K48-linked ubiquitination; MUL1 inactivation leads to UBXN7 accumulation, increased HIF-1α levels, reduced oxidative phosphorylation, and increased glycolysis.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, MUL1 knockout cells, metabolic flux analysis, mitochondrial respiration assay\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP and ubiquitination with KO metabolic phenotype, single lab\",\n      \"pmids\": [\"32005965\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"MUL1 stabilizes PINK1 on the outer mitochondrial membrane in a gemcitabine-dependent manner, independently of mitochondrial depolarization, leading to Parkin-independent mitophagy.\",\n      \"method\": \"Gemcitabine treatment, PINK1 stabilization assay, MUL1 knockdown, mitophagy flux assay\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — knockdown with functional mitophagy readout, single lab\",\n      \"pmids\": [\"32001742\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"MUL1 regulates Akt2 and HIF-1α protein levels through K48-specific polyubiquitination; absence of MUL1 leads to accumulation of both substrates and a metabolic shift from oxidative phosphorylation to glycolysis.\",\n      \"method\": \"MUL1 knockout cells, metabolomics, lipidomics, gene expression profiling, metabolic flux analysis, Akt2 KO cells, chemical inhibitors/activators\",\n      \"journal\": \"Frontiers in cell and developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO with multiple orthogonal metabolic analyses, single lab\",\n      \"pmids\": [\"35846359\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"MAPL/MUL1 promotes Drp1 SUMOylation (SUMO1 modification) in the mitochondria, facilitating Drp1 mitochondrial translocation and mitochondrial fission; SENP5 negatively regulates Drp1 SUMOylation.\",\n      \"method\": \"MAPL overexpression/silencing, Drp1 SUMO-acceptor lysine mutation, AAV in vivo overexpression, SENP5 overexpression, mitochondrial fractionation\",\n      \"journal\": \"Bone research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — mutagenesis and in vivo rescue, single lab\",\n      \"pmids\": [\"40796734\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"MAPL/MUL1 promotes SUMOylation of Drp1 in cardiomyocytes during sepsis; MAPL deficiency reduces Drp1 SUMOylation and Drp1 mitochondrial localization, ameliorating mitochondrial dysfunction and cardiac injury.\",\n      \"method\": \"Cardiomyocyte-specific MAPL KO mice, CLP sepsis model, SUMOylation assay, mitochondrial fractionation, membrane potential and ROS measurements\",\n      \"journal\": \"Journal of translational medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — tissue-specific KO with biochemical and functional readouts, single lab\",\n      \"pmids\": [\"39529130\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"MUL1 SUMOylates HSPA9 at lysine 612, causing HSPA9 export from mitochondria to the nucleus where it interacts with SUZ12 and EZH2, leading to their ubiquitination-mediated degradation and downstream STAT3 pathway inhibition to suppress bladder cancer lymph node metastasis.\",\n      \"method\": \"Co-IP with LC-MS/MS, SUMOylation proteomics, K612R HSPA9 point mutation, mitochondrial dissociation assay, confocal microscopy, in vivo xenograft\",\n      \"journal\": \"International journal of biological sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — site-specific mutagenesis, Co-IP/MS, and in vivo validation, single lab\",\n      \"pmids\": [\"39113711\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"MAPL/MUL1 induces pyroptosis through a pathway in which mitochondrial DNA is trafficked in mitochondrial-derived vesicles to lysosomes, which are permeabilized through gasdermin pores releasing mtDNA into the cytosol to activate cGAS; Parkinson's disease genes VPS35 and LRRK2 also regulate this MAPL-induced pyroptosis pathway.\",\n      \"method\": \"Genome-wide CRISPR functional screen, mtDNA trafficking assay, gasdermin pore assay, cGAS activation assay, primary macrophage depletion experiments\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — genome-wide screen plus multiple orthogonal mechanistic assays including pathway epistasis\",\n      \"pmids\": [\"41083601\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"MAPL loss in mice leads to increased bile acid production coupled with defective regulatory feedback; the peroxisomal bile acid transporter ABCD3 is a primary MAPL interacting partner and is SUMOylated in a MAPL-dependent manner.\",\n      \"method\": \"MAPL knockout mice, BioID proximity labeling, SUMOylation assay, primary hepatocyte cell-autonomous assays, metabolic profiling\",\n      \"journal\": \"EMBO reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO model with BioID and SUMOylation assays, single lab\",\n      \"pmids\": [\"37962001\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"MUL1 promotes degradation of cGAS by enhancing its interaction with MUL1 E3 ligase, a process mediated by HMGB1; GA disrupts HMGB1-cGAS interaction by inducing DOT1L-catalyzed methylation of HMGB1 at lysine 43, thereby promoting cGAS-MUL1 association and cGAS degradation.\",\n      \"method\": \"Co-immunoprecipitation, proteomics, pharmacological assays, scRNA-seq, ubiquitination assay\",\n      \"journal\": \"Journal of translational medicine\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single lab Co-IP and functional assay, mechanistic detail partially indirect\",\n      \"pmids\": [\"41998635\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"MUL1 ubiquitinates FUNDC1 to promote its proteasomal degradation, thereby reducing DRP1 expression and inhibiting DRP1-dependent mitophagy in cervical cancer cells.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, MUL1 overexpression/knockdown, DRP1 knockdown rescue, xenograft model\",\n      \"journal\": \"Journal of molecular histology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — Co-IP and ubiquitination assay in single lab, recent publication with no independent replication\",\n      \"pmids\": [\"41697489\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"SLC44A2 promotes MUL1-mediated ubiquitination and degradation of carnitine palmitoyltransferase 2 (CPT2) by enhancing the physical interaction between MUL1 and CPT2, without altering MUL1 expression levels, thereby inhibiting mitochondrial fatty acid oxidation.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, SLC44A2 KO/overexpression, metabolic assays, in vivo xenograft\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — Co-IP and ubiquitination in single recent study, no independent replication\",\n      \"pmids\": [\"40592838\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"MUL1-mediated SUMOylation of NDP52 at lysine 262 via SUMO2 promotes recruitment of mitochondria to the autophagic pathway through early and recycling endosomal markers (EEA1, RAB11) and autophagy machinery components (ATG3, ATG5, ATG16L1, STX17), regulating mitophagy in cardiac hypertrophy.\",\n      \"method\": \"SUMOylation proteomics, isobaric quantitative proteomics, Co-IP with LC-MS/MS, NDP52 K262R point mutation, confocal microscopy, MUL1 overexpression\",\n      \"journal\": \"Journal of cellular physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — site-specific mutagenesis with orthogonal proteomics and imaging approaches, single lab\",\n      \"pmids\": [\"37942585\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"MUL1 (MULAN/MAPL/GIDE) is a mitochondrial outer membrane-anchored dual E3 ligase (ubiquitin and SUMO) whose cytosol-facing RING domain ubiquitinates substrates including Mitofusin 1/2, Akt, ULK1, UBXN7, HSPA5, FUNDC1, and CPT2 for proteasomal degradation, and SUMOylates substrates including Drp1, RIG-I, NDP52, HSPA9, and ABCD3 to regulate mitochondrial fission/fusion dynamics, ER-mitochondria contacts, mitophagy, antiviral innate immune signaling, NF-κB activation, apoptosis, pyroptosis, and cellular metabolism.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"MUL1 is a mitochondrial outer membrane-anchored dual E3 ligase that uses its cytosol-facing RING finger domain to catalyze both ubiquitination and SUMOylation of diverse substrates, thereby coordinating mitochondrial dynamics, mitophagy, apoptosis, innate immune signaling, and cellular metabolism. As a ubiquitin E3 ligase, MUL1 K48-polyubiquitinates Mitofusin 1/2, Akt, ULK1, UBXN7, HSPA5, and HIF-1α for proteasomal degradation, functioning in parallel with the PINK1/Parkin pathway to maintain mitochondrial integrity and regulate the balance between oxidative phosphorylation and glycolysis [PMID:24898855, PMID:22410793, PMID:32005965, PMID:35846359]. As a SUMO E3 ligase, MUL1 SUMOylates DRP1 to promote mitochondrial fission and stabilize ER–mitochondria contact sites during apoptosis, SUMOylates RIG-I to enable antiviral innate immune activation, and SUMOylates NDP52 and ABCD3 to regulate mitophagy and peroxisomal bile acid transport, respectively [PMID:19407830, PMID:26384664, PMID:28273895, PMID:37942585, PMID:37962001]. MUL1 also drives pyroptosis through a pathway in which mitochondrial DNA is trafficked via mitochondrial-derived vesicles to lysosomes, permeabilized through gasdermin pores, and released into the cytosol to activate cGAS [PMID:41083601].\",\n  \"teleology\": [\n    {\n      \"year\": 2008,\n      \"claim\": \"The identity of MUL1 as a mitochondrial outer membrane E3 ubiquitin ligase was established, resolving how a RING-domain protein anchored to mitochondria could influence both mitochondrial dynamics and NF-κB signaling.\",\n      \"evidence\": \"Ectopic expression, RNAi, domain mutagenesis, and subcellular fractionation in mammalian cells\",\n      \"pmids\": [\"18213395\", \"18591963\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"The endogenous substrates for MUL1 ubiquitin ligase activity were not identified\",\n        \"Mechanism linking MUL1 to NF-κB remained indirect\",\n        \"Whether MUL1 had ligase activities beyond ubiquitination was unknown\"\n      ]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Discovery that MUL1 functions as the first mitochondria-anchored SUMO E3 ligase — SUMOylating DRP1 to stimulate fission — established its dual enzymatic identity and explained how mitochondrial fission is locally regulated.\",\n      \"evidence\": \"In vitro SUMOylation assays, RNAi, and co-immunoprecipitation\",\n      \"pmids\": [\"19407830\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"How SUMOylation of DRP1 mechanistically promotes its mitochondrial recruitment was unclear\",\n        \"Whether SUMO1 vs SUMO2/3 specificity matters was not resolved\"\n      ]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Identification of Akt as a direct ubiquitination substrate revealed MUL1's reach beyond mitochondrial dynamics into growth-factor signaling and cell survival pathways.\",\n      \"evidence\": \"In vitro and in vivo ubiquitination assays, reciprocal Co-IP, cell proliferation assays\",\n      \"pmids\": [\"22410793\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Which Akt isoform is preferentially targeted was not distinguished\",\n        \"Physiological context in which MUL1-Akt regulation is dominant was unknown\"\n      ]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Genetic epistasis across Drosophila and mammals demonstrated that MUL1 ubiquitinates Mitofusin for proteasomal degradation in a pathway parallel to PINK1/Parkin, establishing functional redundancy in mitochondrial quality control.\",\n      \"evidence\": \"Drosophila double-mutant genetics, mouse cortical neuron assays, ubiquitination assays\",\n      \"pmids\": [\"24898855\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether MUL1 preferentially targets Mfn1 vs Mfn2 in different tissues was unresolved\",\n        \"Upstream signals activating MUL1 in the PINK1/Parkin-parallel pathway were unknown\"\n      ]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Identification of MUL1's E2 partners (Ube2E2, Ube2E3, Ube2G2, Ube2L3) and an LIR motif in the RING domain linking MUL1-Ube2E3 to GABARAP provided the first molecular framework for how MUL1 connects ubiquitination to autophagy receptor engagement.\",\n      \"evidence\": \"Modified yeast two-hybrid, Co-IP, LIR mutagenesis\",\n      \"pmids\": [\"25224329\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"LIR-GABARAP interaction not validated by structural methods\",\n        \"Functional contribution of each E2 to distinct substrate ubiquitination not determined\",\n        \"Omi/HtrA2 proteolytic regulation of MUL1 turnover identified in parallel but upstream triggers remain unclear\"\n      ]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"During apoptosis, MUL1-dependent DRP1 SUMOylation was shown to stabilize ER–mitochondria contact sites required for mitochondrial constriction, calcium flux, and cytochrome c release downstream of BAX/BAK, positioning MUL1 as an effector of the intrinsic apoptotic program.\",\n      \"evidence\": \"MAPL KO/KD, live ER-mitochondria imaging, SUMOylation and cytochrome c release assays\",\n      \"pmids\": [\"26384664\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"How BAX/BAK activation signals to MUL1 was not elucidated\",\n        \"Whether MUL1 SUMOylation of DRP1 at ER-mitochondria contacts differs from bulk DRP1 SUMOylation was unknown\"\n      ]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"MUL1 and Parkin were shown to act redundantly in eliminating paternal mitochondria via mitophagy in mouse embryos, demonstrating a physiological requirement for MUL1 in uniparental mitochondrial inheritance.\",\n      \"evidence\": \"Double genetic KO of MUL1 and Parkin in mouse embryos, mitophagy flux assays\",\n      \"pmids\": [\"27852436\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Specific ubiquitination substrates mediating paternal mitophagy were not identified\",\n        \"Whether MUL1's SUMO ligase activity also contributes was untested\"\n      ]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"MUL1 was established as the SUMO E3 ligase for RIG-I, with SUMOylation shown to be a prerequisite for RIG-I activation and antiviral transcription; this resolved earlier observations linking MUL1 to innate immune signaling.\",\n      \"evidence\": \"MAPL KO in vivo and in vitro, BioID proximity labeling, constitutively active RIG-I epistasis\",\n      \"pmids\": [\"28273895\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Which SUMOylation sites on RIG-I are modified by MUL1 was not mapped\",\n        \"How MUL1 is recruited to RIG-I upon viral infection was unclear\"\n      ]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Structural analysis of the MUL1 RING domain revealed a ββαβ fold with canonical cross-brace zinc coordination and direct binding to p53 transactivation domain, providing the first atomic-resolution view of substrate recognition by this ligase.\",\n      \"evidence\": \"NMR solution structure and chemical shift perturbation mapping\",\n      \"pmids\": [\"31235254\", \"35048531\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Full-length MUL1 structure including transmembrane anchors remains undetermined\",\n        \"Whether p53 ubiquitination by MUL1 is physiologically significant in vivo is unknown\"\n      ]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"MUL1 KO in neurons demonstrated that MUL1 antagonizes Mfn2-mediated ER-mitochondria tethering; loss of MUL1 elevates Mfn2, disrupts ER-mitochondria calcium coupling, and paradoxically triggers calcineurin-dependent DRP1 activation and Parkin-mediated mitophagy.\",\n      \"evidence\": \"MUL1 KO neurons, live imaging of ER-mitochondria contacts, calcium measurements, Mfn2 overexpression phenocopy, calcineurin inhibition\",\n      \"pmids\": [\"31409786\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether this feedback loop operates in non-neuronal cells was not tested\",\n        \"Direct calcineurin-DRP1 dephosphorylation in this context was not biochemically reconstituted\"\n      ]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Identification of UBXN7 and Akt2/HIF-1α as MUL1 ubiquitination substrates established that MUL1 regulates the metabolic switch between oxidative phosphorylation and glycolysis by controlling HIF-1α stability through multiple converging mechanisms.\",\n      \"evidence\": \"MUL1 KO cells, metabolic flux analysis, ubiquitination assays, metabolomics/lipidomics\",\n      \"pmids\": [\"32005965\", \"35846359\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether MUL1 directly ubiquitinates HIF-1α or only indirectly controls it via UBXN7/Akt2 was not fully resolved\",\n        \"Tissue-specific metabolic consequences in vivo not characterized\"\n      ]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Expansion of MUL1's SUMO substrate repertoire to include NDP52 (mitophagy receptor) and ABCD3 (peroxisomal transporter) showed that MUL1 SUMOylation regulates organelle-specific processes beyond mitochondria, including peroxisomal bile acid metabolism and endosome-mediated mitophagy.\",\n      \"evidence\": \"SUMOylation proteomics, site-specific mutagenesis (NDP52 K262R), BioID, MAPL KO mice with metabolic profiling\",\n      \"pmids\": [\"37942585\", \"37962001\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"How MUL1 on the mitochondrial outer membrane accesses peroxisomal ABCD3 is mechanistically unclear\",\n        \"Whether NDP52 SUMOylation is required for mitophagy in vivo has not been tested\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"A genome-wide CRISPR screen revealed that MUL1 induces pyroptosis by directing mitochondrial DNA through mitochondrial-derived vesicles to lysosomes, which are permeabilized by gasdermin pores to release mtDNA into the cytosol for cGAS activation — linking MUL1 to Parkinson's disease genes VPS35 and LRRK2.\",\n      \"evidence\": \"Genome-wide CRISPR screen, mtDNA trafficking assays, gasdermin pore assays, cGAS activation, primary macrophage experiments\",\n      \"pmids\": [\"41083601\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"The direct MUL1 substrate(s) initiating mitochondrial-derived vesicle formation for this pathway are unknown\",\n        \"Whether MUL1-driven pyroptosis contributes to neurodegeneration in Parkinson's disease models has not been tested\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"A full-length structural model of MUL1 including its transmembrane domains and the basis for substrate selectivity between ubiquitination and SUMOylation remain unresolved; how upstream signals dynamically regulate MUL1 activity and its partitioning between dual ligase functions is unknown.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No full-length structure of MUL1 including transmembrane domains exists\",\n        \"Mechanism by which MUL1 switches between ubiquitin and SUMO E3 ligase activities is unknown\",\n        \"Upstream regulatory signals controlling MUL1 enzymatic activity under physiological conditions are largely uncharacterized\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 1, 2, 3, 5, 7, 13, 16, 17, 19, 26, 27, 28]},\n      {\"term_id\": \"GO:0016874\", \"supporting_discovery_ids\": [0, 3, 5, 13, 17]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [0, 1, 4, 6, 14]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [6, 7, 8, 28]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [2, 4, 23]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [10, 11]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [17, 19, 24]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 5, 12]},\n      {\"term_id\": \"R-HSA-1852241\", \"supporting_discovery_ids\": [1, 3, 14, 20, 21]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"DRP1\",\n      \"MFN2\",\n      \"AKT1\",\n      \"RIG-I\",\n      \"UBXN7\",\n      \"NDP52\",\n      \"TRAF2\",\n      \"ABCD3\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}